Volume 4 (2020), Issue 3
Complete issue
Editorial
Editorial
Page 139 - 141
Articles
Duplicate Marketing Authorisations in the EU: Evolution of the Regulatory Framework and Practical Implications
Page 142 - 152
Lost on the High Seas without a Safe Harbor or a Shield? Navigating Cross-Border Transfers in the Pharmaceutical Sector After Schrems II Invalidation of the EU-US Privacy Shield open-access
Page 153 - 160
Stem Cell Based Products in Europe and in China: Where are We and Where Should we Go?
Page 161 - 171
The Impact of the Medical Devices Regulation on the Pharmaceutical Industry: A Focus on Combination Products and Digital Health Technologies
Page 172 - 182
Jurisdiction
Jurisdiction
Page 183 - 186
Legislation
New EU Pharmaceutical Law and Policy
Page 187 - 188